The LD 500 Archives - Page 20 of 21

TuesdaySep 01, 2020 10:20 am

BioCardia Inc. (NASDAQ: BCDA) Starts Presentation at The LD 500

BioCardia Inc. (NASDAQ: BCDA) is a clinical-stage regenerative medicine company. Headquartered in San Carlos, California, BioCardia is developing regenerative biologic therapies to treat cardiovascular disease. The company's CardiAMP autologous and NK1R+ allogenic cell therapies are biotherapeutic platforms currently in clinical development. BioCardia's products include the Helix biotherapeutic delivery system and its steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix system and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit the company's website at www.biocardia.com About…

TuesdaySep 01, 2020 10:20 am

Artelo Biosciences Inc. (NASDAQ: ARTL) Starts Presentation at The LD 500

Artelo Biosciences Inc. (NASDAQ: ARTL) is a biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system and related biological signaling pathways. Artelo is applying true biopharma discipline toward rapidly advancing a diverse portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com About The LD…

TuesdaySep 01, 2020 10:00 am

Heritage Global Inc. (CSE: HGP) (OTCQB: HGBL) Starts Presentation at The LD 500

Heritage Global Inc. (CSE: HGP) (OTCQB: HGBL) is an asset services company specializing in financial and capital assets. The company provides a full suite of services including market making, acquisitions, dispositions, valuations and secured lending. Heritage Global focuses on identifying, valuing, acquiring and monetizing underlying tangible and intangible assets across 28 global sectors. The company acts as an adviser, as well as a principal, acquiring or brokering turnkey manufacturing facilities, surplus industrial machinery and equipment, industrial inventories, accounts receivable portfolios, intellectual property and entire business enterprises. For more information, visit the company's website at www.hginc.com About The LD 500 The…

TuesdaySep 01, 2020 10:00 am

Chicken Soup for the Soul Entertainment Inc. (NASDAQ: CSSE) Starts Presentation at The LD 500

Chicken Soup for the Soul Entertainment Inc. (NASDAQ: CSSE) operates streaming video-on-demand networks (VOD). The company owns a majority stake in Crackle Plus, a company formed with Sony Pictures Television, which owns and operates a variety of ad-supported and subscription-based VOD networks, including Crackle, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix and FrightPix. The company also acquires and distributes video content through its Screen Media subsidiary and produces original long- and short-form content through Landmark Studio Group, its Chicken Soup for the Soul Originals division and APlus.com. Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the…

TuesdaySep 01, 2020 10:00 am

Digirad Corp. (NASDAQ: DRAD) Starts Presentation at The LD 500

Digirad Corp. (NASDAQ: DRAD) is a diversified holding company with three divisions: health care, building and construction, and real estate and investments. Digirad is the nationwide leader in delivering diagnostic expertise on an as-needed, when-needed, where-needed basis. Recognized by Insights Success Magazine as one of the 'Top 10 Fastest Growing Healthcare Solution Provider Companies', Digirad makes health care convenient through its unique model of on-demand, direct to point-of-service health care to thousands of providers across the country. For more information, visit the company's website at www.digirad.com About The LD 500 The LD 500 is the most ambitious project in LD…

TuesdaySep 01, 2020 10:00 am

Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT) Starts Presentation at The LD 500

Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT) is a leading provider of innovative network intelligence and security solutions that empower communications service providers and enterprises worldwide, bringing enhanced value to customers. Allot's solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services and more. With more than 20 years of proven success, Allot's solutions turn network, application, usage and security data into actionable intelligence, making customers' networks smarter and their users more secure. Allot's multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1,000 enterprises. Allot's industry-leading, network-based security…

TuesdaySep 01, 2020 9:40 am

U.S. Gold Corp. (NASDAQ: USAU) Starts Presentation at The LD 500

U.S. Gold Corp. (NASDAQ: USAU) is a publicly traded, U.S.-focused gold exploration company. U.S. Gold Corp. has a portfolio of exploration properties. Copper King is located in Southeast Wyoming and has a preliminary economic assessment (PEA) technical report, which was completed by Mine Development Associates. Keystone and Maggie Creek are exploration properties on the Cortez and Carlin Trends in Nevada. For more information, visit the company's website at www.usgoldcorp.gold About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates from…

TuesdaySep 01, 2020 9:40 am

Conversion Labs Inc. (OTCQB: CVLB) Starts Presentation at The LD 500

Conversion Labs Inc. (OTCQB: CVLB) is a telemedicine company with a portfolio of online direct-to-consumer brands. The company's brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. Conversion Labs is applying its direct-response marketing expertise to health care and providing a convenient, cost-effective and smarter way for consumers to access high-quality OTC products and prescription medications. For more information, visit the company's website at www.conversionlabs.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's…

TuesdaySep 01, 2020 9:40 am

InfuSystems Holdings Inc. (NYSE American: INFU) Starts Presentation at The LD 500

InfuSystems Holdings Inc. (NYSE American: INFU) is a leading provider of infusion pumps and related durable medical equipment support services to hospitals, clinics and other alternate site health care providers. InfuSystem provides pole-mounted and ambulatory pumps and supplies, along with related clinical, biomedical and billing services, to practices and patients nationwide. Headquartered in Rochester Hills, Michigan, the company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada. For more information, visit the company's website at www.infusystem.com About The LD 500 The LD 500 is the most ambitious project in LD…

TuesdaySep 01, 2020 9:40 am

Lineage Cell Therapeutics Inc. (NYSE American: LCTX) Starts Presentation at The LD 500

Lineage Cell Therapeutics Inc. (NYSE American: LCTX) is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage's clinical programs are in markets with billion-dollar opportunities and include three allogeneic ("off-the-shelf") product candidates: (i) OpRegen(R), a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in…